Home Cart 0 Sign in  
X

[ CAS No. 23000-43-3 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
HazMat Fee +

There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.

Type HazMat fee for 500 gram (Estimated)
Excepted Quantity USD 0.00
Limited Quantity USD 15-60
Inaccessible (Haz class 6.1), Domestic USD 80+
Inaccessible (Haz class 6.1), International USD 150+
Accessible (Haz class 3, 4, 5 or 8), Domestic USD 100+
Accessible (Haz class 3, 4, 5 or 8), International USD 200+
3d Animation Molecule Structure of 23000-43-3
Chemical Structure| 23000-43-3
Chemical Structure| 23000-43-3
Structure of 23000-43-3 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 23000-43-3 ]

Related Doc. of [ 23000-43-3 ]

Alternatived Products of [ 23000-43-3 ]

Product Details of [ 23000-43-3 ]

CAS No. :23000-43-3 MDL No. :MFCD00661967
Formula : C6H5ClN4 Boiling Point : -
Linear Structure Formula :- InChI Key :AVFLNALVPBLGEV-UHFFFAOYSA-N
M.W : 168.58 Pubchem ID :219751
Synonyms :

Calculated chemistry of [ 23000-43-3 ]

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.17
Num. rotatable bonds : 0
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 41.59
TPSA : 43.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.8 cm/s

Lipophilicity

Log Po/w (iLOGP) : 1.68
Log Po/w (XLOGP3) : 0.75
Log Po/w (WLOGP) : 1.02
Log Po/w (MLOGP) : 0.74
Log Po/w (SILICOS-IT) : 1.12
Consensus Log Po/w : 1.06

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.96
Solubility : 1.84 mg/ml ; 0.0109 mol/l
Class : Very soluble
Log S (Ali) : -1.25
Solubility : 9.59 mg/ml ; 0.0569 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.34
Solubility : 0.776 mg/ml ; 0.0046 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.71

Safety of [ 23000-43-3 ]

Signal Word:Danger Class:6.1
Precautionary Statements:P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P310-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501 UN#:2811
Hazard Statements:H301-H315-H319-H335 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 23000-43-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 23000-43-3 ]
  • Downstream synthetic route of [ 23000-43-3 ]

[ 23000-43-3 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 5399-92-8 ]
  • [ 74-88-4 ]
  • [ 23000-43-3 ]
YieldReaction ConditionsOperation in experiment
70.8%
Stage #1: With sodium hydride In N,N-dimethyl-formamide at 0℃; for 0.5 h;
A suspension of compound 2 (1.88 g, 0.012 mol) andNaH (0.864 g, 0.036 mol) in dry DMF (10 mL) was stirred at 0 °C for 30 min. Iodomethane (2.56 g,0.018 mol) was added, and the resulting mixture was stirred overnight. The reaction mixture wastreated with water (100 mL) and extracted with EtOAc (60 mL x 3). The combined organic layers wereremoved in vacuo to give compound 6. Yield: 70.8percent; 1H-NMR (400 MHz, DMSO-d6) δ 8.85 (s, 1H),8.44 (s, 1H), 4.08 (s, 3H).
38.5% With caesium carbonate In N,N-dimethyl-formamide at 0 - 20℃; In a 250 mL three-necked flask, 4-chloro-1H-pyrazolo[3,4-d]pyrimidine (2.0 g, 12.98 mmol), DMF (50 mL) and cesium carbonate (5.06 g, 15.57 mmol) were successively added.Cool to 0°C in an ice bath, methyl iodide (0.97 mL,15.57 mmol) was diluted with DMF (5 mL) and slowly added dropwise using a dropping funnel. Dripping to room temperature,Overnight, monitored by TLC. After the reaction was completed, the reaction solution was diluted with ethyl acetate (100 mL), and the mixture was washed with water (60 mL×1) and saturated NaCl solution (50 mL×2), respectively. Anhydrous MgSO4 was dried, the solvent was evaporated and dried to give a white solid (1.67 g, yield 38.5percent).
38.5% With caesium carbonate In N,N-dimethyl-formamide at 0 - 20℃; General procedure: A suspension of compound 3 (6.5mmol) and Cs2CO3 (13.0mol) in dry DMF (25mL) was stirred at 0°C for 30min, and then iodide alkane (7.8mmol) was added. After stirring overnight, the reaction mixture was extracted with EtOAc (60mL× 3), washed with water, dried over Na2SO4, and concentrated in vacuo to give compound 4.
Reference: [1] Comptes Rendus Chimie, 2017, vol. 20, # 9-10, p. 927 - 933
[2] Molecules, 2017, vol. 22, # 4,
[3] Patent: CN107383014, 2017, A, . Location in patent: Paragraph 0079; 0080; 0081; 0082
[4] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 210 - 228
  • 2
  • [ 5305-40-8 ]
  • [ 60-34-4 ]
  • [ 23000-43-3 ]
YieldReaction ConditionsOperation in experiment
92%
Stage #1: With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0℃; for 0.166667 h; Inert atmosphere
Stage #2: at 0 - 20℃; for 1 h; Inert atmosphere
General procedure: To a 20 mL vial was added 1 (97percent, 88 mg, 0.5 mmol), Et3N (0.070mL, 0.5 mmol), and THF (1 mL). The reaction mixture was allowed to stir at 0 °C for 10 min under a N2 atmosphere. To the solution was added hydrazine monohydrate (2p; 0.026 mL, 0.525 mmol) in THF (1 mL) dropwise. The reaction mixture was allowed to warm to r.t. and stirred for 1 h. The solvent was removed in vacuo, and the residue was partitioned between CH2Cl2 (6 mL) and H2O (10 mL). The layers were separated, and the aqueous layer was extracted with CH2Cl2 (2 × 6 mL). The combined organic layers were dried(MgSO4) and concentrated in vacuo to obtain 4p; yield: 56 mg(74percent);
53% With N-ethyl-N,N-diisopropylamine In tetrahydrofuran at 0 - 20℃; for 3.16667 h; Example 2-Synthesis of 4-chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine 2
To 4,6-dichloro-pyrimidine-5-carbaldehyde (2.90 g, 16.39 g) and diisopropylethylamine (2.12 g, 2.85 mL, 16.39 mmol) in THF (100 mL) cooled at 0° C. was added dropwise methylhydrazine (0.83 g, 0.95 mL, 18.03 mmol) in 10 mL THF.
The reaction mixture was stirred at 0° C. for 10 min, and warmed to room temperature and stirred for 3 h.
Then, the solvent was removed at reduced pressure and the crude was chromatographed by Biotage (DCM: EtOAc) to afford 1.47 g, 53percent of the desired compound as a white solid. 1H NMR (300 MHz, CDCl3): δ 8.79 (s, 1H), 8.17 (s, 1H), 4.17 (s, 3H).
13C NMR (75 MHz, CDCl3): δ 154.83, 154.53, 153.23, 131.90, 113.65, 34.47.
Reference: [1] Synthesis (Germany), 2013, vol. 45, # 13, p. 1791 - 1806
[2] Patent: US2017/355700, 2017, A1, . Location in patent: Paragraph 0100
[3] Tetrahedron Letters, 2008, vol. 49, # 52, p. 7395 - 7397
[4] Patent: US2009/5359, 2009, A1, . Location in patent: Page/Page column 19
  • 3
  • [ 5334-56-5 ]
  • [ 23000-43-3 ]
YieldReaction ConditionsOperation in experiment
85% With thionyl chloride In N,N-dimethyl-formamide for 2 h; Reflux Step 1)Synthetic 1-methyl-pyrazolo[3,4-d]pyrimidin-4-one (2 g, 13.3 mmol)Add to 20 mL of dry thionyl chloride,After adding 1ml DMF to the reaction system,Heat reflux reaction for 2h,Cool to room temperature, evaporate the solvent under reduced pressure, and add the residue to ice water.Saturated sodium bicarbonate was adjusted to pH 7 and extracted with ethyl acetate (2 x 50 mL).The organic phase is washed with saturated sodium bicarbonate solution.Washing, drying over anhydrous sodium sulfate, rotary evaporation of the solvent,Obtained pale yellow solid 1.91g, yield 85percent,
85% With thionyl chloride In N,N-dimethyl-formamide for 2 h; Reflux The 1-methyl-pyrazole [3,4-d]pyrimidin-4-one (2 g, 13.3 mmol) synthesized in step 1) was added to 20 mL of dry thionyl chloride, and 1 ml of DMF was added to the reaction system. After heating, the reaction is refluxed for 2 hours.After cooling to room temperature, the solvent was evaporated under reduced pressure, and the residue was added to ice water. The pH was adjusted to 7 with saturated sodium bicarbonate and extracted with ethyl acetate (2×50 mL). The organic phase was washed with saturated sodium bicarbonate solution, and washed with water. Sodium sulfate drying, rotary evaporation of the solvent to give a pale yellow solid 1.91g, yield 85percent,HPLC: 96.69percent.
60.5% With trichlorophosphate In Petroleum ether (d)
1-Methyl-4-chloropyrazolo[3,4-d]pyrimidine
80 g. of 1-methyl-1,5-dihydro-4H-pyrazolo[3,4-d]- pyrimidin-4-one are added to 300 ml. of phosphorus oxychloride and the mixture is refluxed.
After distilling off the excess phosphorus oxychloride, the semi-solid residue is extracted with 3 * 100 ml. of boiling benzene.
The benzene extracts are combined and concentrated to half-volume, then added to petroleum ether.
After standing 12 hours in the refrigerator, the precipitated 1-methyl-4-chloropyrazolo[3,4-d]- pyrimidine is filtered under suction and recrystallized from cyclohexane to obtain 54 g. of white crystals, m.p. 93°-96° (yield 60.5percent).
Reference: [1] Patent: CN107778316, 2018, A, . Location in patent: Paragraph 0036-0038
[2] Patent: CN107955008, 2018, A, . Location in patent: Paragraph 0034; 0038; 0040
[3] Patent: US4124764, 1978, A,
  • 4
  • [ 5399-92-8 ]
  • [ 74-88-4 ]
  • [ 23000-43-3 ]
  • [ 959430-67-2 ]
YieldReaction ConditionsOperation in experiment
22% With caesium carbonate In N,N-dimethyl-formamide at 0℃; for 3 h; Compound 80; 4-Chloro-2-methyl-2H-pyrazolo[3,4-d]pyrimidine; Compound 81; 4-Chloro-1-methyl-2H-pyrazolo[3,4-d]pyrimidine; Cesium carbonate (Acros, 2.12 g, 6.51 mmol) was added to compound 79 (1.00 g, 5.9 mmol) in N,N-dimethylformamide (Acros, 30 mL) at 0° C. followed immediately by methyl iodide (Acros, 1.01 g, 7.1 mmol). The mixture was stirred for three hours. Cesium carbonate was removed by filtration and the filter cake was washed with a small amount of DMF. The filtrate and washings were concentrated and the reaction mixture was subjected to flash chromatography on silica gel (gradient elution 9:1 to 4:1 to 0:1 dichloromethane:ethyl acetate) to afford two white solids: Compound 80 (220 mg, 22percent) elutes second and Compound 81 (663 mg, 67percent) elutes first. Compound 80: mp 196-200° C.; MS (ES+calculated: 168.59; found: 169.57 M+H). HPLC (100percent purity, retention time 4.627 minutes-Method B); 1H NMR (300 MHz, DMSO-d6): 8.91 (s, 1H), 8.90 (s, 1H), 4.25 (s, 3H). Compound 81: mp 97-99° C.; MS (ES+calculated: 168.59; found: 169.37 M+H). HPLC (100percent purity, retention time 6.582 minutes-Method B); 1H NMR (400 MHz, DMSO-d6) δ 8.98 (s, 1H), 8.48 (s, 1H), 4.09 (s, 3H).
Reference: [1] Patent: US2007/281949, 2007, A1, . Location in patent: Page/Page column 37
[2] Journal of Organic Chemistry, 2018, vol. 83, # 12, p. 6334 - 6353
[3] Journal of Organic Chemistry, 2018, vol. 83, # 12, p. 6334 - 6353
  • 5
  • [ 7339-53-9 ]
  • [ 5305-40-8 ]
  • [ 23000-43-3 ]
Reference: [1] Organic Letters, 2013, vol. 15, # 8, p. 1882 - 1885
  • 6
  • [ 5305-40-8 ]
  • [ 23000-43-3 ]
Reference: [1] Molecules, 2017, vol. 22, # 4,
[2] Patent: CN107383014, 2017, A,
[3] European Journal of Medicinal Chemistry, 2018, vol. 155, p. 210 - 228
  • 7
  • [ 6288-86-4 ]
  • [ 23000-43-3 ]
Reference: [1] Heterocycles, 1994, vol. 39, # 1, p. 345 - 356
  • 8
  • [ 31037-02-2 ]
  • [ 23000-43-3 ]
Reference: [1] Patent: CN107955008, 2018, A,
[2] Patent: US4124764, 1978, A,
  • 9
  • [ 5334-56-5 ]
  • [ 23000-43-3 ]
Reference: [1] Journal of Medicinal Chemistry, 2003, vol. 46, # 23, p. 4910 - 4925
  • 10
  • [ 315-30-0 ]
  • [ 23000-43-3 ]
Reference: [1] Comptes Rendus Chimie, 2017, vol. 20, # 9-10, p. 927 - 933
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 23000-43-3 ]

Chlorides

Chemical Structure| 21254-15-9

[ 21254-15-9 ]

4-Chloro-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.96

Chemical Structure| 100644-66-4

[ 100644-66-4 ]

4-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine

Similarity: 0.92

Chemical Structure| 98141-42-5

[ 98141-42-5 ]

4,6-Dichloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.91

Chemical Structure| 864292-48-8

[ 864292-48-8 ]

4,6-Dichloro-1-ethyl-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.90

Chemical Structure| 5399-92-8

[ 5399-92-8 ]

4-Chloro-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.88

Related Parent Nucleus of
[ 23000-43-3 ]

Other Aromatic Heterocycles

Chemical Structure| 21254-15-9

[ 21254-15-9 ]

4-Chloro-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.96

Chemical Structure| 100644-66-4

[ 100644-66-4 ]

4-Chloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidin-6-amine

Similarity: 0.92

Chemical Structure| 98141-42-5

[ 98141-42-5 ]

4,6-Dichloro-1-methyl-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.91

Chemical Structure| 864292-48-8

[ 864292-48-8 ]

4,6-Dichloro-1-ethyl-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.90

Chemical Structure| 5399-92-8

[ 5399-92-8 ]

4-Chloro-1H-pyrazolo[3,4-d]pyrimidine

Similarity: 0.88